BioSpace News Archive

Biotech Bay

Lucira Health Submits EUA for Over-The-Counter (OTC) Use of its COVID-19 & Flu Test

Lucira Health, Inc., a medical technology company, announced that it submitted an Emergency Use Authorization application to the FDA for OTC use of its simple, at-home molecular COVID-19 & Flu test.

January 3, 2023
·
3 min read
Biotech Bay

Revolution Medicines to Present at 41st Annual J.P. Morgan Healthcare Conference

Revolution Medicines, Inc. announced that Mark A. Goldsmith, M.D., Ph.D., the company’s chief executive officer and chairman, will deliver a corporate presentation as part of the 41st Annual J.P. Morgan Healthcare Conference.

January 3, 2023
·
1 min read
Antengene to Present at the 41st Annual J.P. Morgan Healthcare Conference

Antengene Corporation Limited announced that Antengene will present at the 41st Annual J.P. Morgan Healthcare Conference on Wednesday, January 11th, 2023 at 9:30 a.m. PST in San Francisco, California.

January 3, 2023
·
3 min read
Drug Development

Sensorion Announces First Patient Enrolled in Phase 2a Proof of Concept Clinical Trial of SENS-401 in Cisplatin-Induced Ototoxicity

Sensorion announces that the first patient has been enrolled in its Phase 2a Proof of Concept clinical trial of SENS-401 in patients suffering from Cisplatin-Induced Ototoxicity.

January 3, 2023
·
6 min read
Genetown

Minovia Therapeutics to Present at Biotech Showcase on Tuesday, January 10, 2023Company to be in San Francisco January 8-12, 2023, during 41st Annual J.P. Morgan Health Care Conference

Minovia Therapeutics announced that the Company will be presenting at the Biotech Showcase on Tuesday, January 10, 2023, at the Hilton San Francisco Union Square Hotel in San Francisco, CA.

January 3, 2023
·
1 min read
Drug Development

Apnimed Completes Oversubscribed $79.75 Million Series C Extension Financing to Fund Two Planned Phase 3 Trials of AD109, an Oral Medication with the Potential to Be the First Therapy for Direct Treatment of Obstructive Sleep Apnea (OSA)

Apnimed, Inc., a clinical-stage pharmaceutical company focused on developing oral pharmacologic therapies for the treatment of obstructive sleep apnea and related disorders, announced that it has secured $79.75 million in an oversubscribed financing round that extends its Series C financing to a total of $142.25 million.

January 3, 2023
·
4 min read
Genetown

Karuna Therapeutics to Present at the 41st Annual J.P. Morgan Healthcare Conference

Karuna Therapeutics, Inc. announced that Bill Meury, president and chief executive officer, will present at the 41st Annual J.P. Morgan Healthcare Conference on Tuesday, January 10, 2023, at 9:00 a.m. PST.

January 3, 2023
·
1 min read
Bio NC

Asensus Announces Kitakyushu General Hospital in Japan to Initiate Second Senhance System

Asensus Surgical, Inc. announced that Kitakyushu General Hospital, a hospital in the Kyushu area of Japan, entered into an agreement to lease and utilize a second Senhance® Surgical System, at the end of December 2022.

January 3, 2023
·
5 min read
Genetown

C4 Therapeutics to Present at the 41st Annual J.P. Morgan Healthcare Conference

C4 Therapeutics, Inc. announced that the Company will present at the upcoming 41st Annual J.P. Morgan Healthcare Conference in San Francisco on Monday, January 9th at 10:30 am PST.

January 3, 2023
·
1 min read
Pharm Country

SpringWorks Therapeutics to Present at the 41st Annual J.P. Morgan Healthcare Conference

SpringWorks Therapeutics, Inc. announced that Saqib Islam, Chief Executive Officer, will present at the 41st Annual J.P. Morgan Healthcare Conference on Monday, January 9, 2023 at 7:30 a.m. PT.

January 3, 2023
·
1 min read